drugset
drugset / Trial / NCT05952531

Characterizing Myositis With 68Ga-FAPI PET/CT

NCT05952531 ↗

Phase 0 Unknown 50 enrolled The First Affiliated Hospital of Xiamen University
NaSingle-groupOpen-labelDiagnostic

Summary

To evaluate the potential usefulness of 68Ga-FAPI PET/CT for the diagnosis and evaluation of systemic involvement in idiopathic inflammatory myopathies (IIM)/myositis, and compared the results with those of 18F-FDG PET/CT.

Timeline

Start
2023-07-01
Primary completion
2024-07
Completion
2025-07

Drugs

EvaluationDrugModalityDoseRoute
Subject FAPI GA-68 Diagnostic / imaging agent — Intravenous

Indications

idiopathic inflammatory myopathy